TTMFN: Two-stream Transformer-based Multimodal Fusion Network for Survival Prediction

TL;DR

This paper introduces TTMFN, a novel deep learning framework using transformer-based multimodal fusion to improve cancer survival prediction by effectively integrating and analyzing pathological images and gene expression data.

Contribution

The paper proposes a two-stream transformer-based model with co-attention and multi-head pooling for enhanced multimodal feature fusion in survival prediction.

Findings

Achieves superior performance on TCGA datasets.

Effectively models complex inter-modality relationships.

Outperforms or matches state-of-the-art methods.

Abstract

Survival prediction plays a crucial role in assisting clinicians with the development of cancer treatment protocols. Recent evidence shows that multimodal data can help in the diagnosis of cancer disease and improve survival prediction. Currently, deep learning-based approaches have experienced increasing success in survival prediction by integrating pathological images and gene expression data. However, most existing approaches overlook the intra-modality latent information and the complex inter-modality correlations. Furthermore, existing modalities do not fully exploit the immense representational capabilities of neural networks for feature aggregation and disregard the importance of relationships between features. Therefore, it is highly recommended to address these issues in order to enhance the prediction performance by proposing a novel deep learning-based method. We propose a novel framework named Two-stream Transformer-based Multimodal Fusion Network for survival prediction (TTMFN), which integrates pathological images and gene expression data. In TTMFN, we present a two-stream multimodal co-attention transformer module to take full advantage of the complex relationships between different modalities and the potential connections within the modalities. Additionally, we develop a multi-head attention pooling approach to effectively aggregate the feature representations of the two modalities. The experiment results on four datasets from The Cancer Genome Atlas demonstrate that TTMFN can achieve the best performance or competitive results compared to the state-of-the-art methods in predicting the overall survival of patients.